Literature DB >> 2439090

The immunologic detection and characterization of cartilage proteoglycan degradation products in synovial fluids of patients with arthritis.

J Witter, P J Roughley, C Webber, N Roberts, E Keystone, A R Poole.   

Abstract

Antibodies were used in radioimmunoassays with gel chromatography to detect the hyaluronic acid-binding region, core protein, and keratan sulfate of human cartilage proteoglycan in the synovial fluids of patients with rheumatoid arthritis, juvenile rheumatoid arthritis, and osteoarthritis. All fluids contained proteoglycan that was mainly included on Sepharose CL-4B; this result indicates cleavage of proteoglycan (which is normally excluded). The hyaluronic acid-binding region was the smallest and most commonly detected fragment. It was relatively free of keratan sulfate and core protein, and it could sometimes bind to hyaluronic acid. Other larger fragments containing core protein and/or keratan sulfate were detected in every fluid.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2439090     DOI: 10.1002/art.1780300506

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  31 in total

1.  Studies of a monoclonal antibody to skeletal keratan sulphate. Importance of antibody valency.

Authors:  A R Poole; C Webber; A Reiner; P J Roughley
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

2.  Citrullinated Aggrecan Epitopes as Targets of Autoreactive CD4+ T Cells in Patients With Rheumatoid Arthritis.

Authors:  Cliff Rims; Hannes Uchtenhagen; Mariana J Kaplan; Carmelo Carmona-Rivera; Philip Carlucci; Katalin Mikecz; Adrienn Markovics; Jeffrey Carlin; Jane H Buckner; Eddie A James
Journal:  Arthritis Rheumatol       Date:  2019-03-08       Impact factor: 10.995

Review 3.  The danger from within: alarmins in arthritis.

Authors:  Meriam Nefla; Dirk Holzinger; Francis Berenbaum; Claire Jacques
Journal:  Nat Rev Rheumatol       Date:  2016-10-13       Impact factor: 20.543

4.  Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1.

Authors:  G R Dodge; A R Poole
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

5.  Changes in cartilage proteoglycan aggrecan after intra-articular injection of interleukin-1 in rabbits: studies of synovial fluid and articular cartilage.

Authors:  C Lundberg; I Asberg; M Ionescu; A Reiner; G Smedegård; A R Poole
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

6.  Increased concentrations of proteoglycan components in the synovial fluids of patients with acute but not chronic joint disease.

Authors:  A Ratcliffe; M Doherty; R N Maini; T E Hardingham
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

7.  The identification and characterization of two populations of aggregating proteoglycans of high buoyant density isolated from post-natal human articular cartilages of different ages.

Authors:  C Webber; T T Glant; P J Roughley; A R Poole
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

8.  Development of a cleavage-site-specific monoclonal antibody for detecting metalloproteinase-derived aggrecan fragments: detection of fragments in human synovial fluids.

Authors:  A J Fosang; K Last; P Gardiner; D C Jackson; L Brown
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

9.  Comparison of mobility changes with histological and biochemical changes during lipopolysaccharide-induced arthritis in the hamster.

Authors:  I G Otterness; M L Bliven; A J Milici; A R Poole
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

10.  Comparison of keratan sulphate concentrations and the size distribution of proteoglycans in the synovial fluid of patients with osteoarthritis and pyrophosphate arthropathy.

Authors:  G Carroll; S McCappin; M Bell; A Schwarzer; P Breidahl
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.